Skip to content

Caring for caregivers (C4C)

Caring For Carers (C4C): Pilot randomised controlled trial of Positive Written Disclosure for Older Adult Carers of people with psychosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN79116352
Enrollment
60
Registered
2017-01-23
Start date
2017-01-09
Completion date
Unknown
Last updated
2024-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Mental Health, Primary sub-specialty: Study not assigned to a MH Clinical Studies Group

Interventions

At the start of the study, the statistician responsible for randomisation will generate a group allocation sequence that will link participant IDs to either positive written disclosure (PWD), writing

Sponsors

University of Sussex
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Classified as a primary caregiver as defined by the Royal College of General Practitioners (2011, p. 9): “any person who provides unpaid support to a partner, child, relative or friend who couldn’t manage to live independently or whose health or wellbeing would deteriorate without this help.” 2. Aged 50 years or over 3. Providing care for someone with a psychosis diagnosis - psychosis is defined here as including the following diagnoses: 3.1. Schizophrenia 3.2. Schizoaffective disorder 3.3. Schizotypal Personality Disorder 3.4. Delusional disorder 3.5. Psychosis not otherwise specified 3.6. Bipolar 3.7. Depression with psychotic features 4. Able to read, write and communicate in English

Exclusion criteria

Exclusion criteria: Currently receiving or have confirmed plans to engage in psychological therapy of any form (including family therapies).

Design outcomes

Primary

MeasureTime frame
Mood is measured using the Positive and Negative Affect Scale (PANAS) at baseline, 1, 3 and 6 months.

Secondary

MeasureTime frame
1. Symptoms of anxiety and depression are measured using the Depression Anxiety and Stress Scale (DASS 21) at baseline, 1, 3 and 6 months 2. Self-efficacy is measured using the General Self-Efficacy Scale (GSES) at baseline, 1, 3 and 6 months 3. Wellbeing is measured using the Caregiver Wellbeing and Support Scale (CWSv2) at baseline, 1, 3 and 6 months 4. Alexithymia is measured using the Toronto Alexithymia Scale (TAS 20) at baseline only 5. General health and health economics is measured using the EQ-5D at baseline, 1, 3 and 6 months 6. Satisfaction with leisure activities is measured using the Leisure Time Satisfaction Measure (LTS) at baseline, 1, 3 and 6 months Feasibility outcomes: 1. Recruitment rate is measured as the proportion of participant who provide consent, compared to those who are referred, at baseline. 2. Retention rate is measured as the percentage of participants that provide data at all time points (baseline, and 1, 3 and 6 months) at the end of the study 3. Adherence to the intervention is measured as the percentage of participants that complete writing on all three days, the percentage of participants that write for 20 minutes each day, and the percentage of participants that complete their writing on the three consecutive days, at the end of the study

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 8, 2026